Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 30:4:809-16.
doi: 10.2147/opth.s7631.

Retinal vein occlusion: pathophysiology and treatment options

Niral Karia  1
Affiliations

Retinal vein occlusion: pathophysiology and treatment options

Niral Karia. Clin Ophthalmol. .

Abstract

This paper reviews the current thinking about retinal vein occlusion. It gives an overview of its pathophysiology and discusses the evidence behind the various established and emerging treatment paradigms.

Keywords: branch; central; hemispheric; retinal vein occlusion; visual loss.

PubMed Disclaimer

References

    1. Cugati S, Wang JJ, Rochtchina E, et al. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol. 2006;124:726–732. - PubMed
    1. Hayreh S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retinal Eye Res. 2005;24:493–519. - PubMed
    1. Cheung N, Klein R, Wang J, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci. 2008;49:4297–4302. - PMC - PubMed
    1. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126:513–518. - PubMed
    1. Dexamethasone 700 μg intravitreal implant in applicator for retinal vein occlusion. Allergan advance notification document. 2009 Oct.